Sameena Sharif, Ph.D.
Sameena Sharif, Ph.D., is the Chief Operating Officer of QED. Dr. Sharif brings over 20 years of experience in project and alliance management in both the biotech and pharmaceutical sectors, working in roles of increasing responsibility at Aradigm, Abgenix, PDL, Exelixis and Cellerant Therapeutics. Most recently, she was at Astex Pharmaceuticals Inc as Vice President of Business Operations, Portfolio Planning and Project Management with accountability for delivery all development stage programs. Her experience covers all aspects of drug development from target selection through filing including work on Guadecitabine, Vectibix® and Retavase®. Dr. Sharif obtained her B. Pharmacy Degree from Bradford University, UK and her PhD in Pharmaceutical Sciences from the University of Nottingham, UK.